CareCloud (CareCloud) COGS-to-Revenue : 0.58 (As of Mar. 2024)

View and export this data going back to 2014. Start your Free Trial

What is CareCloud COGS-to-Revenue?

CareCloud's Cost of Goods Sold for the three months ended in Mar. 2024 was $15.2 Mil. Its Revenue for the three months ended in Mar. 2024 was $26.0 Mil.

CareCloud's COGS to Revenue for the three months ended in Mar. 2024 was 0.58.

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin. CareCloud's Gross Margin % for the three months ended in Mar. 2024 was 41.54%.

CareCloud COGS-to-Revenue Historical Data

The historical data trend for CareCloud's COGS-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

CareCloud COGS-to-Revenue Chart

CareCloud Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

COGS-to-Revenue

Get a 7-Day Free Trial

0.64

0.62

0.61

0.60

CareCloud Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
COGS-to-Revenue	Get a 7-Day Free Trial															0.60	0.60	0.62	0.60	0.58

CareCloud COGS-to-Revenue Calculation

CareCloud's COGS to Revenue for the fiscal year that ended in Dec. 2023 is calculated as

COGS to Revenue	=	Cost of Goods Sold	/	Revenue
	=	70.817	/	117.059
	=	0.60

CareCloud's COGS to Revenue for the quarter that ended in Mar. 2024 is calculated as

COGS to Revenue	=	Cost of Goods Sold	/	Revenue
	=	15.177	/	25.962
	=	0.58

CareCloud (NAS:CCLD) COGS-to-Revenue Explanation

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin.

CareCloud's Gross Margin % for the three months ended in Mar. 2024 is calculated as:

Gross Margin %	=	1	-	COGS to Revenue
	=	1	-	Cost of Goods Sold / Revenue
	=	1	-	15.177 / 25.962
	=	41.54 %

A company that has a moat can usually maintain or even expand their Gross Margin. A company can increase its Gross Margin in two ways. It can increase the prices of the goods it sells and keeps its Cost of Goods Sold unchanged. Or it can keep the sales price unchanged and squeeze its suppliers to reduce the Cost of Goods Sold. Warren Buffett believes businesses with the power to raise prices have moats.

CareCloud COGS-to-Revenue Related Terms

Thank you for viewing the detailed overview of CareCloud's COGS-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.

CareCloud (CareCloud) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » CareCloud Inc (NAS:CCLD) » Definitions » COGS-to-Revenue

Comparable Companies

Traded in Other Exchanges

CCLDP.PFD:USA MTB0:Germany MTB:Germany

Address

7 Clyde Road, Somerset, NJ, USA, 08873

Website

https://www.carecloud.com

CareCloud Inc is a healthcare information technology company. It provides a full suite of proprietary cloud-based solutions and related business services. Its Software-as-a-Service platforms include practice management (PM), electronic health record (EHR), business intelligence, telehealth, patient experience management (PXM) solutions, and robotic processing automation (RPA) bots, along with complementary software tools and business services such as revenue cycle management (RCM), premiere healthcare consulting and implementation services, and on-demand workforce staffing capabilities for high-performance medical groups and health systems nationwide. The operating segments of the group are Healthcare IT, which is the key revenue generating segment, and Practice Management.

Executives

Mahmud Ul Haq	director, 10 percent owner, officer: Chief Executive Officer	7 CLYDE ROAD, SOMERSET NJ 08873
Lawrence Steven Sharnak	director	7393, ORANGEWOOD LANE, BOCA RATON FL 33433
Anne Busquet	director	390 PARK AVE 4TH FLR, NEW YORK NY 10022
A Hadi Chaudhry	officer: President	7 CLYDE ROAD, SOMERSET NJ 08873
Nathalie Grey Garcia	officer: General Counsel & Secretary	7 CLYDE ROAD, SOMERSET NJ 08873
Lawrence J. Steenvoorden	officer: Chief Financial Officer	C/O CHEMBIO DIAGNOSTICS, INC., 555 WIRELESS BOULEVARD, HAUPPAUGE NY 11788
Stephen Andrew Snyder	director, officer: President	7 CLYDE ROAD, SOMERSET NJ 08873
Bill Korn	officer: Chief Financial Officer	61 DARREN DRIVE, BASKING RIDGE NJ 07920
John N Daly	director	390 STANWICH ROAD, GREENWICH CT 06830
Kimberly J Grant	officer: General Counsel & Secretary	7 CLYDE ROAD, SOMERSET NJ 08873
Cameron Munter	director	295 WEST ORANGE GROVE AVE, SIERRA MADRE CA 91024
Shruti H Patel	officer: Interim Corporate Secretary	7 CLYDE ROAD, SOMERSET NJ 08873
Amritpal K. Deol	officer: See Remarks	7 CLYDE ROAD, SOMERSET NJ 08873
Norman Roth	officer: See Remarks	7 CLYDE ROAD, SOMERSET NJ 08873
Brendan Patrick Harney	officer: See Remarks	7 CLYDE ROAD, SOMERSET NJ 08873